Search for: "Eli Lilly & Co."
Results 841 - 860
of 1,004
Sort by Relevance
|
Sort by Date
15 Jan 2009, 3:10 am
This just in 20 minutes ago from the AP.INDIANAPOLIS January 15, 2009, 10:56 am ET · Eli Lilly & Co. said Thursday it pleaded guilty to a charge that it illegally marketed the anti-psychotic drug Zyprexa for an unapproved use, and will pay $1.42 billion to settle civil suits and end the criminal investigation.OK folks. [read post]
14 Jan 2009, 3:23 pm
When Berenson began calling around for comment and seemed to possess remarkably detailed information about the negotiations, Eli Lilly initially believed that the source of the leak had been the government. [read post]
14 Jan 2009, 11:41 am
Eli Lilly Co. is expected to pay $1.4 billion to settle the government's criminal and civil claims against the company in connection with its marketing of Zyprexa, according to this article in the New York Times, which notes the record-breaking... [read post]
8 Jan 2009, 4:07 am
Eli Lilly & Co., 536 F. [read post]
6 Jan 2009, 9:14 am
Eli Lilly: - This addresses patent validity and enforceability issues where Lilly contends that the asserted claims of US 6,410,516 are invalid for including non-statutory subject matter, for being obtained through inequitable conduct, and are unenforceable due to prosecution laches. [read post]
23 Dec 2008, 1:00 pm
Eli Lilly & Co., 577 F. [read post]
18 Dec 2008, 10:36 pm
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983)). [read post]
17 Dec 2008, 9:48 am
Durch die Entscheidung wurde ein Patent des Unternehmens Eli Lilly and Co Ltd., welches den pharmazeutischen Wirkstoff “Olanzapin” betrifft, für nichtig erklärt. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic… [read post]
11 Dec 2008, 10:30 pm
Eli Lilly & Co. v. [read post]
9 Dec 2008, 8:35 am
" Eli Lilly and Co. v. [read post]
29 Nov 2008, 6:16 pm
In an effort to quell public anger, pharmaceutical giant Eli Lilly & Co. says it will create a "public database" listing the names of the physicians on Lilly's payroll for speaking engagements and consulting services. [read post]
26 Nov 2008, 5:39 pm
Sidley and Pepper Hamilton have advised Eli Lilly & Co. in entering into settlements with both federal and state prosecutors that will eventually top $2 billion, mostly over the fraudulent marking of the antipsychotic drug Zyprexa. [read post]
22 Nov 2008, 12:06 pm
Lately Kolkata Patent Office issued an Indian Patent No. 225209 to Eli Lilly & Co. for crystalline non-solvated anhydrous Arzoxifene. [read post]
18 Nov 2008, 10:40 pm
Wockhardt is lately been sued by Eli Lilly & Co. for alleged infringement of OB listed patent for antidepressant drug Cymbalta, generically Duloxetine. [read post]
6 Nov 2008, 3:08 am
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
30 Oct 2008, 11:34 am
It is a twice daily injection which is sold in a pre-filled pen by Amylin Pharmaceuticals and Eli Lilly & Co. [read post]
24 Oct 2008, 1:09 pm
As reported by the Indianapolis Star, Eli Lilly and Co. announced Tuesday that it is prepared to pay more than $1.4 billion to settle state and federal investigations related to the drugmaker's marketing of the antipsychotic medication Zyprexa. [read post]
17 Oct 2008, 3:06 pm
Eli Lilly & Co. has agreed to pay $62 million to some states, to settle claims it improperly marketed Zyprexa, its top-selling drug, to patients who did not have schizophrenia or bipolar disorder, its only approved uses. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
